Marisa Sánchez-Ferrer
No ORCID on file
· 1 paper in corpus
· active 2005
BACKGROUND: To analyze the therapeutic results of one dose of 3 million IU of recombinant interleukin-2 (rIL-2) left intracyst (group I) versus two doses with a 1-month interval (group II) after transvaginal ultrasound (US)-guided drainage …